Company — Civitas Therapeutics
Developing and commercializing transformative therapeutics for treating Parkinson’s disease. (ACQR, Acquired by Acorda Therapeutics)
Developing and commercializing transformative therapeutics for treating Parkinson’s disease. (ACQR, Acquired by Acorda Therapeutics)